I

IMRX PE Valuation

This table applies IMRX's historical price-to-earnings (PE) landmarks to current earnings. The implied prices are valuation scenarios, not price forecasts or targets.

I

IMRX Earnings Per Share

This chart tracks IMRX's trailing twelve-month diluted earnings per share, calculated from four consecutive reported quarters to reduce seasonal noise.

I

IMRX Quarterly Revenue

This chart tracks IMRX's quarterly revenue over time and shows how sales are changing from year to year.

I

IMRX Free Cash Flow

This chart tracks IMRX's free cash flow over time, showing whether the business is consistently generating cash after operating costs and capital spending.

I

IMRX Net Leverage

Quarterly Net Leverage uses the last 12 months of EBITDA. A falling multiple generally indicates less debt relative to earnings capacity. Negative values mean net cash; missing data or nonpositive LTM EBITDA are N/A. The table shows each period’s Net Leverage and status.

I

IMRX Weekly Price

This chart uses IMRX's weekly closing prices to show the longer-term trend. The lower panes show weekly RSI and Stochastic momentum.

I

IMRX Weekly Moving Averages

This chart compares IMRX's 8, 20, 50, 100, and 200-week moving averages from 2020 onward. Shorter averages react faster to price changes, while longer averages show the broader trend.

I

IMRX Yearly ROI

Each line starts at 0% using the year’s first dependable weekly close and tracks the return through December, or through the latest available week for the current year.